-
Balamurugan V, Hosamani M, Jayappa K D, Venkatesan B, Chauhan R, Singh A, 2009: A polymerase chain reaction strategy for the diagnosis of camelpox[J]. Vet Diag Invest, 21, 231-237. doi: 10.1177/104063870902100209
-
Binns M, Mumford J, Wernery W, 1992: Analysis of the Camelpox virus thymidine kinase gene[J]. Br Vet J, 148, 541-546. doi: 10.1016/0007-1935(92)90010-X
-
Dietzschold B, Wunner W H, Wiktor T J, Lopes A D, Lafon M, Smith C L, Koprowski H, 1983: Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus[J]. Proc Natl Acad Sci. USA, 80, 70-74. doi: 10.1073/pnas.80.1.70
-
Duraffour S, Meyer H, Andrei G, Snoeck R, 2011: Camelpox virus[J]. Antiviral Res, 92, 167-86. doi: 10.1016/j.antiviral.2011.09.003
-
Hafez S M, Al-Sukayran A, Dela Cruz D M, Mazloum K S, Al-Bokmy A M, Al-Mukayel A, Amjad A M, 1992: Development of a live cell culture camelpox vaccine[J]. Vaccine, 10, 533-537. doi: 10.1016/0264-410X(92)90353-L
-
Khalafalla A I, Mohamed M E M, 1996: Clinical and epizootiological features of camelpox in eastern Sudan[J]. J Camel Pract and Res, 2, 99-102.
-
Khalafalla A I, Mohamed M E H, Ali B H, 1998: Camel pox in the Sudan[J]. 1-isolation and identification of the causative virus. J Camel Pract and Res, 5, 229-233.
-
Laidlaw S M, Skinner M A, 2004: Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of fowlpox virus, with those of virulent American and European viruses[J]. J Gen Virol, 85, 305-322. doi: 10.1099/vir.0.19568-0
-
Massung R F, Esposito J J, Liu L Q, Utterback T R, Knight J C, Aubin L, Yuran T E, Parsons J M, Loparev V N, Selivanov N A, Cavallaro K F, Kerlavage A R, Mahy B W, Venter J C, 1993: Potential virulence determinants in terminal regions of variola smallpox virus genome[J]. Nature, 366, 748-751. doi: 10.1038/366748a0
-
Monath T P, 2005: Yellow fever vaccine[J]. Expert Rev. Vaccines, 4, 553-574. doi: 10.1586/14760584.4.4.553
-
Nguyen Ba-Vy, Guerre L, Martin-Sant G, 1996: Etude preliminaire de I innocuite e du pouvoir immunogene de la ouche attenuee VD47/25 de camelpox virus[J]. Revue de Elev Med Vet Pays trop, 49, 189-194.
-
Perkus M E, Goebel S J, Davis S W, Johnson G P, Limbach K, Norton E K, Paoletti E, 1991: Deletion of 55 open reading frames from the termini for vaccinia virus[J]. Virology, 180, 406-410. doi: 10.1016/0042-6822(91)90047-F
-
Pfeffer M, Meyer H, Wernery U, Kaaden O R, 1996: Comparison of camelpox viruses isolated in Dubai[J]. Vet Microbiol, 49, 135-146. doi: 10.1016/0378-1135(95)00181-6
-
Singh R K, Balamurugan V, Hosamani M, Kallesh D J, Bhanuprakash V, 2008: Sequence analysis of C18L gene of buffalopox virus:PCR strategy for specific detection and differentiation of buffalopox from orthopoxviruses[J]. J Virol Methods, 154, 146-153. doi: 10.1016/j.jviromet.2008.08.009
-
Tulman E R, Afonso C L, Lu Z, Zsak L, Sur J H, Sandybaev N T, Karembekova U Z, Zaitsev V L, Kutish G F, Rock D L, 2002: The genomes of sheeppox and goatpox viruses[J]. J Virol, 76, 6054-6061. doi: 10.1128/JVI.76.12.6054-6061.2002
-
Westrop G D, Wareham K A, Evans D M, Dunn G, Minor P D, Magrath D I, Taffs F, Marsden S, Skinner M A, Schild G C, Almond J W, 1989: Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine[J]. J Virol, 63, 1338-1344.
-
Wernery U, Kaaden O R. 2002. Camel pox. In: Infectious Diseases in Camelids, Second Edition, Wernery U, Kaaden O R, eds, Blackwell Science Berlin, Vienna: 176-185.
-
Wernery U, Zachariah R, 1999: Experimental camelpox infection in vaccinated and unvaccinated dromedaries[J]. J Vet Med (B) Infect Dis, 46, 131-136.